<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04326660</url>
  </required_header>
  <id_info>
    <org_study_id>18-27025</org_study_id>
    <nct_id>NCT04326660</nct_id>
  </id_info>
  <brief_title>SCOPE-Chinese Women Study</brief_title>
  <acronym>SCOPE</acronym>
  <official_title>The Smartphone-Based Cancer and Obesity Prevention Education Program for Chinese Women (SCOPE-Chinese Women)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Central South University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project examines the feasibility of a smartphone-based intervention to reduce obesity
      and breast cancer risk among Chinese women in China. The proposed intervention is to use the
      mobile application and an activity tracker device to promote a healthier lifestyle and
      physical activity. The intervention will be tailored to the participants' behaviors, personal
      needs, and preferences. The aim is to reduce abdominal obesity and improve healthy lifestyle
      behaviors in premenopausal women with children in order to reduce the growing cancer burden
      in China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cancer presents a major disease burden across the globe. The incidence and mortality of
      gynecologic cancers have increased significantly in China over the last two decades with
      breast and endometrial cancer as leading causes of death in women in China. Obesity,
      especially abdominal obesity, and unhealthy lifestyles are major risk factors for breast and
      endometrial cancer. A high risk group for obesity is mothers with dependent children as they
      have high levels of stress and family responsibilities that prevent regular engagement in a
      healthy lifestyle and early screening activities. Because reducing postmenopausal abdominal
      obesity is very difficult and because of the significant increased risk for gynecologic
      cancers in obese postmenopausal women, interventions that aim to reduce abdominal obesity and
      improve healthy lifestyle behaviors in premenopausal women with children are critical to
      reducing the growing cancer burden in China. A smartphone-based intervention provides a
      promising platform for obesity and cancer prevention. In this proposed study, the research
      team will modify the Healthy Mothers Healthy Children: Technology-Based Intervention to
      Prevent Obesity, which was developed by the principal investigator. The proposed intervention
      (titled &quot;The Smartphone-Based Cancer and Obesity Prevention Education Program for Chinese
      Women: SCOPE-Chinese Women&quot;) is a smartphone-based, data-driven, and individually tailored
      intervention. It includes 12 weekly educational modules and six bi-weekly tailored messages
      delivered via WeChat, a popular communication app in China. The intervention will also be
      tailored to the participants' behaviors, personal needs, and preferences. The overall goal of
      this proposed study is to assess the feasibility and estimate the preliminary efficacy of the
      SCOPE-Chinese Women intervention using a randomized control study design (RCT). The following
      aims will be addressed.

      Aim 1: To assess the feasibility of the smartphone-based lifestyle intervention (i.e.,
      SCOPE-Chinese Women).

      Aim 2: To estimate the preliminary efficacy of the SCOPE-Chinese Women intervention on the
      primary outcome (waist circumference) and secondary outcomes (body mass index, self-efficacy,
      food intake, physical activity, and metabolic risk) between the intervention and control
      groups at baseline, 3 months, and 6 months.

      Aim 3: To understand participants' acceptance, barriers to adherence, and recommendations for
      intervention.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 20, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This pilot study will utilize a randomized control trail design with a control group. A total of 66 women who meet the inclusion criteria will be included in the study. Thirty-three participants in the intervention group and 33 participants in the control group will be enrolled. In this study, the control group participants will receive 12 non- tailored women's health educational modules via WeChat. The intervention group will receive the SCOPE-Chinese Women smartphone based intervention.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>To decrease cross-contamination of treatment effect, the six study sites will be the units of randomization. A Statistical Package for Social Sciences (SPSS) program will be used to statistically match the groups and to randomly assign each study group. Basic demographic characteristics will be collected for each study site.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Waist Circumference</measure>
    <time_frame>Baseline, 3 months, and 6 months</time_frame>
    <description>We will use the National Institutes of Health (NIH) waist circumference measurement protocol to measure change in waist circumference.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>Baseline, 3 months, and 6 months</time_frame>
    <description>We will measure weight and height and compute the BMI with the formula=weight [kg]/height [m]2 and measure change in BMI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Efficacy</measure>
    <time_frame>Baseline, 3 months, and 6 months</time_frame>
    <description>We will use the &quot;28-Item Self-Rated Abilities for Health Practices Scale&quot; to measure change in self efficacy on nutrition, stress management, and physical activity. This survey is rated on a 5-point scale. From 0-Not at all, to 4-Completely.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Food Intake</measure>
    <time_frame>Baseline, 3 months, and 6 months</time_frame>
    <description>We will measure food intake using the China food frequency questionnaire (FFQ), which includes 118 food items to measure change in food intake.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity</measure>
    <time_frame>Baseline, 3 months, and 6 months</time_frame>
    <description>Physical activity will be measured with the Fitbit Alta-HR for 10 hours while participants are awake to measure change in physical activity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>Baseline, 3 months, and 6 months</time_frame>
    <description>Blood pressure will be measured with the monitor YuWell YE690A to measure change in blood pressure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1C</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>There will be a HemoglobinA1C cut off at 6.4%. Hemoglobin A1C will be measured with a blood sample to measure change in hemoglobin A1C.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum lipids</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Serum lipids will be measured with a blood sample to measure change in serum lipids.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Cortisol will be measured with a blood sample to measure change in cortisol.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Enrollment</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>We will measure the number of eligible participants and percentage of eligible participants who agree to be screened to measure change in enrollment.</description>
  </other_outcome>
  <other_outcome>
    <measure>Usability</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>We will measure the number of uses of the tracking app and frequency of accessing the 12 modules, to measure change in usability.</description>
  </other_outcome>
  <other_outcome>
    <measure>Demographics</measure>
    <time_frame>Collected at baseline</time_frame>
    <description>We will determine demographics by collecting data on the participant's age, education level, household income.</description>
  </other_outcome>
  <other_outcome>
    <measure>Adherence</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>We will measure the percentage of completed assessments to measure adherence.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Cancer, Breast</condition>
  <condition>Obesity, Abdominal</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in the control group will receive a Fitbit Alta-Heart Rate (HR) and 12 weekly non-tailored educational modules via WeChat on general health topics that are important to 20-45 year-old women in China. Topics include intimate partner violence, anxiety, depression, sexually transmitted infections, HIV, unintended pregnancy, hepatitis B, and general cancer prevention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SCOPE-Chinese Women Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SCOPE-Chinese Women intervention content and methods: SCOPE-Chinese Women is a smartphone- based intervention.
Component 1. All study participants will receive a Fitbit Alta-HR tracking device to wear daily. Each participant will receive in-person, training on how to access the app and their tracking data. If a participant has not used the fitness device and app for more than one week, a WeChat reminder message will be sent to the participant.
Component 2. Participants will receive 12 weekly culturally appropriate and evidence-based SCOPE-Chinese Women educational modules along with tailored tips and messages via WeChat. Each module will include three educational sessions that last less than 45 minutes total.
Component 3. Six bi-weekly messages will be sent to participants via WeChat to encourage positive behavioral changes. Each participant's message content will be based on the participant's tracker information, personal goals, and preferences.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>SCOPE-Chinese Women</intervention_name>
    <description>SCOPE-Chinese Women is a smart-phone based intervention that includes a Fitbit tracking device to monitor daily activity, 12-weeks of educational modules delivered by WeChat, and Bi-weekly messages that encourage positive behavioral change. The data will be examined by the research team to assess efficacy of the intervention.</description>
    <arm_group_label>SCOPE-Chinese Women Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Participants must:

          -  Be female

          -  Be at least 18 years old

          -  Have a waist circumference great than 80 cm

          -  Own a smartphone

          -  Be able to read Chinese and speak Mandarin

          -  Be premenopausal

          -  Have a child between the age of 1 and 18 years old

        Exclusion Criteria:

        Women are excluded from the study if they:

          -  Are pregnant

          -  Gave birth less than 12 months prior to enrollment date

          -  Have an acute or life-threatening disease (e.g., renal failure).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jyu-Lin Chen, RN, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jia Guo, RN, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central South Univeristy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jyu-Lin Chen, RN, PhD</last_name>
    <phone>415-502-6015</phone>
    <email>Jyu-Lin.Chen@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jia Guo, RN, PhD</last_name>
    <email>guojia621@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central South University</name>
      <address>
        <city>Yuelu</city>
        <state>Changsha, Hunan</state>
        <zip>410083</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Jia Guo, RN, PhD</last_name>
      <email>guojia621@163.com</email>
    </contact>
    <investigator>
      <last_name>Jia Guo, RN, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Qian Lin, RN, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Feng Zheng, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE. Breast cancer in China. Lancet Oncol. 2014 Jun;15(7):e279-89. doi: 10.1016/S1470-2045(13)70567-9. Review.</citation>
    <PMID>24872111</PMID>
  </reference>
  <reference>
    <citation>Jiang X, Tang H, Chen T. Epidemiology of gynecologic cancers in China. J Gynecol Oncol. 2018 Jan;29(1):e7. doi: 10.3802/jgo.2018.29.e7. Review.</citation>
    <PMID>29185265</PMID>
  </reference>
  <reference>
    <citation>Fair AM, Dai Q, Shu XO, Matthews CE, Yu H, Jin F, Gao YT, Zheng W. Energy balance, insulin resistance biomarkers, and breast cancer risk. Cancer Detect Prev. 2007;31(3):214-9. Epub 2007 Jul 23.</citation>
    <PMID>17646056</PMID>
  </reference>
  <reference>
    <citation>Wang X, Li L, Gao J, Liu J, Guo M, Liu L, Wang W, Wang J, Xing Z, Yu Z, Wang X. The Association Between Body Size and Breast Cancer in Han Women in Northern and Eastern China. Oncologist. 2016 Nov;21(11):1362-1368. doi: 10.1634/theoncologist.2016-0147. Epub 2016 Aug 5.</citation>
    <PMID>27496041</PMID>
  </reference>
  <reference>
    <citation>Cutrona CE, Abraham WT, Russell DW, Beach SR, Gibbons FX, Gerrard M, Monick M, Philibert R. Financial strain, inflammatory factors, and haemoglobin A1c levels in African American women. Br J Health Psychol. 2015 Sep;20(3):662-79. doi: 10.1111/bjhp.12120. Epub 2014 Oct 18.</citation>
    <PMID>25327694</PMID>
  </reference>
  <reference>
    <citation>Landstedt E, Harryson L, Hammarstr√∂m A. Changing housework, changing health? A longitudinal analysis of how changes in housework are associated with functional somatic symptoms. Int J Circumpolar Health. 2016 Jun 30;75:31781. doi: 10.3402/ijch.v75.31781. eCollection 2016.</citation>
    <PMID>27369590</PMID>
  </reference>
  <reference>
    <citation>Berge JM, Larson N, Bauer KW, Neumark-Sztainer D. Are parents of young children practicing healthy nutrition and physical activity behaviors? Pediatrics. 2011 May;127(5):881-7. doi: 10.1542/peds.2010-3218. Epub 2011 Apr 11.</citation>
    <PMID>21482603</PMID>
  </reference>
  <reference>
    <citation>Liu Y, Warren Andersen S, Wen W, Gao YT, Lan Q, Rothman N, Ji BT, Yang G, Xiang YB, Shu XO, Zheng W. Prospective cohort study of general and central obesity, weight change trajectory and risk of major cancers among Chinese women. Int J Cancer. 2016 Oct 1;139(7):1461-70. doi: 10.1002/ijc.30187. Epub 2016 May 31.</citation>
    <PMID>27177094</PMID>
  </reference>
  <reference>
    <citation>Sun A, Cheng J, Bui Q, Liang Y, Ng T, Chen JL. Home-Based and Technology-Centered Childhood Obesity Prevention for Chinese Mothers With Preschool-Aged Children. J Transcult Nurs. 2017 Nov;28(6):616-624. doi: 10.1177/1043659617719139. Epub 2017 Jul 8.</citation>
    <PMID>28826348</PMID>
  </reference>
  <reference>
    <citation>Guan X, Sun G, Zheng L, Hu W, Li W, Sun Y. Associations between metabolic risk factors and body mass index, waist circumference, waist-to-height ratio and waist-to-hip ratio in a Chinese rural population. J Diabetes Investig. 2016 Jul;7(4):601-6. doi: 10.1111/jdi.12442. Epub 2015 Dec 26.</citation>
    <PMID>27181937</PMID>
  </reference>
  <reference>
    <citation>Wen X, Mai J, Gao X, Guo M, Wu Y, Liu X, Zhao L. [Cut-off values of waist circumference for central obesity in Chinese adults]. Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Sep;43(9):822-6. Chinese.</citation>
    <PMID>26652826</PMID>
  </reference>
  <reference>
    <citation>Nanayakkara J, Lekamwasam S. Validity of BMI, hip and waist circumferences as surrogate measures of obesity in a cohort of Sri Lankan premenopausal women. Ceylon Med J. 2013 Jun;58(2):72-5. doi: 10.4038/cmj.v58i2.4720.</citation>
    <PMID>23817937</PMID>
  </reference>
  <reference>
    <citation>Singhal N, Mathur P, Pathak R. Validity of simple, novel measures of generalized and central obesity among young Asian Indian women. Indian J Med Sci. 2011 Dec;65(12):518-27. doi: 10.4103/0019-5359.109901.</citation>
    <PMID>23548252</PMID>
  </reference>
  <reference>
    <citation>Yu R, Yan LL, Wang H, Ke L, Yang Z, Gong E, Guo H, Liu J, Gu Y, Wu Y. Effectiveness of a community-based individualized lifestyle intervention among older adults with diabetes and hypertension, Tianjin, China, 2008-2009. Prev Chronic Dis. 2014 May 15;11:E84. doi: 10.5888/pcd11.120333.</citation>
    <PMID>24831288</PMID>
  </reference>
  <reference>
    <citation>Zhang R, Li Y, Zhang S, Cai X, Zhou X, Ji L. The Association of Retinopathy and Plasma Glucose and HbA1c: A Validation of Diabetes Diagnostic Criteria in a Chinese Population. J Diabetes Res. 2016;2016:4034129. Epub 2016 Oct 11.</citation>
    <PMID>27807545</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2020</study_first_posted>
  <last_update_submitted>July 13, 2020</last_update_submitted>
  <last_update_submitted_qc>July 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Abdominal</keyword>
  <keyword>Cancer Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Abdominal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

